Secondary progressive multiple sclerosis: current knowledge and future challenges

@article{Rovaris2006SecondaryPM,
  title={Secondary progressive multiple sclerosis: current knowledge and future challenges},
  author={M. Rovaris and C. Confavreux and R. Furlan and L. Kappos and M. Filippi},
  journal={The Lancet Neurology},
  year={2006},
  volume={5},
  pages={343-354}
}
  • M. Rovaris, C. Confavreux, +2 authors M. Filippi
  • Published 2006
  • Medicine
  • The Lancet Neurology
  • The secondary progressive phase of multiple sclerosis (MS), which is characterised by a steady accrual of fixed disability after an initial relapsing remitting course, is not clearly understood. Although there is no consensus on the mechanisms underlying such a transition to the progressive phase, epidemiological and neuroimaging studies indicate that it is probably driven by the high prevalence of neurodegenerative compared with inflammatory pathological changes. This notion is lent support by… CONTINUE READING
    247 Citations

    Topics from this paper

    Paper Mentions

    Interventional Clinical Trial
    The purpose of this clinical trial is to determine if Domperidone in a dose of 40 mg daily can prevent worsening of walking ability in people secondary progressive MS. The number of… Expand
    ConditionsMultiple Sclerosis, Secondary Progressive
    InterventionDrug
    Secondary Progressive Multiple Sclerosis: What is in the
    • 7
    • PDF
    Secondary Progressive Multiple Sclerosis: Definition and Measurement
    • 23
    • PDF
    Progressive multiple sclerosis: from pathogenic mechanisms to treatment.
    • 143
    • PDF
    The natural history of secondary progressive multiple sclerosis
    • 213
    • PDF
    Progression in multiple sclerosis: Further evidence of an age dependent process
    • 79
    Sequencing of high-efficacy disease-modifying therapies in multiple sclerosis: perspectives and approaches
    • 4

    References

    SHOWING 1-10 OF 148 REFERENCES
    The natural history of multiple sclerosis
    • 73
    Primary and secondary progressive multiple sclerosis
    • 41
    The window of therapeutic opportunity in multiple sclerosis
    • 447
    Primary and transitional progressive MS
    • 140
    Primary progressive multiple sclerosis.
    • 236
    • PDF